[HTML][HTML] Current drugs to treat infections with herpes simplex viruses-1 and-2
LA Sadowski, R Upadhyay, ZW Greeley, BJ Margulies - Viruses, 2021 - mdpi.com
Herpes simplex viruses-1 and-2 (HSV-1 and-2) are two of the three human
alphaherpesviruses that cause infections worldwide. Since both viruses can be acquired in …
alphaherpesviruses that cause infections worldwide. Since both viruses can be acquired in …
Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management
Herpes simplex viruses (HSV) type 1 and type 2 are responsible for recurrent orolabial and
genital infections. The standard therapy for the management of HSV infections includes …
genital infections. The standard therapy for the management of HSV infections includes …
Antiviral drug resistance of human cytomegalovirus
NS Lurain, S Chou - Clinical microbiology reviews, 2010 - Am Soc Microbiol
The study of human cytomegalovirus (HCMV) antiviral drug resistance has enhanced
knowledge of the virological targets and the mechanisms of antiviral activity. The currently …
knowledge of the virological targets and the mechanisms of antiviral activity. The currently …
[HTML][HTML] Advances and perspectives in the management of varicella-zoster virus infections
G Andrei, R Snoeck - Molecules, 2021 - mdpi.com
Varicella-zoster virus (VZV), a common and ubiquitous human-restricted pathogen, causes a
primary infection (varicella or chickenpox) followed by establishment of latency in sensory …
primary infection (varicella or chickenpox) followed by establishment of latency in sensory …
[HTML][HTML] New strategies against drug resistance to herpes simplex virus
YC Jiang, H Feng, YC Lin, XR Guo - International journal of oral …, 2016 - nature.com
Herpes simplex virus (HSV), a member of the Herpesviridae family, is a significant human
pathogen that results in mucocutaneous lesions in the oral cavity or genital infections …
pathogen that results in mucocutaneous lesions in the oral cavity or genital infections …
[HTML][HTML] CMV: prevention, diagnosis and therapy
CN Kotton - American Journal of Transplantation, 2013 - Elsevier
Cytomegalovirus (CMV) is the most common infection after organ transplantation and has a
major impact on morbidity, mortality and graft survival. Optimal prevention, diagnosis and …
major impact on morbidity, mortality and graft survival. Optimal prevention, diagnosis and …
[HTML][HTML] Rational approaches to improving selectivity in drug design
Appropriate tuning of binding selectivity is a primary objective in the discovery and
optimization of a compound on the path toward developing a drug. The environment in …
optimization of a compound on the path toward developing a drug. The environment in …
International consensus guidelines on the management of cytomegalovirus in solid organ transplantation
Cytomegalovirus (CMV) remains one of the most common infections after solid organ
transplantation, resulting in significant morbidity, graft loss, and occasional mortality …
transplantation, resulting in significant morbidity, graft loss, and occasional mortality …
[HTML][HTML] Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016
AJ Ullmann, M Schmidt-Hieber, H Bertz, WJ Heinz… - Annals of …, 2016 - Springer
Infectious complications after allogeneic haematopoietic stem cell transplantation (allo-HCT)
remain a clinical challenge. This is a guideline provided by the AGIHO (Infectious Diseases …
remain a clinical challenge. This is a guideline provided by the AGIHO (Infectious Diseases …
Update on human herpesvirus 6 biology, clinical features, and therapy
L De Bolle, L Naesens, E De Clercq - Clinical microbiology …, 2005 - Am Soc Microbiol
SUMMARY Human herpesvirus 6 (HHV-6) is a betaherpesvirus that is closely related to
human cytomegalovirus. It was discovered in 1986, and HHV-6 literature has expanded …
human cytomegalovirus. It was discovered in 1986, and HHV-6 literature has expanded …